Functional analyses revealed that high-risk tumors are characterized by a distinct immune-tumor uncoupling phenotype, in which interferon-gamma (IFNG)-associated inflammatory signaling is preserved but fails to translate into effective antitumor immune activity. Here, IFNG is linked to neoplasm.